Global Blood Therapeutics Inc
F:G5B
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
G
|
Global Blood Therapeutics Inc
F:G5B
|
US |
|
Halliburton Co
NYSE:HAL
|
US |
|
D
|
Daesung Holdings Co Ltd
KRX:016710
|
KR |
|
AFK Sistema PAO
MOEX:AFKS
|
RU |
|
C
|
Chow Steel Industries PCL
SET:CHOW
|
TH |
|
GetBusy PLC
LSE:GETB
|
UK |
|
Comtech Telecommunications Corp
NASDAQ:CMTL
|
US |
|
APT Systems Inc
OTC:APTY
|
US |
|
Dynacor Gold Mines Inc
TSX:DNG
|
CA |
|
L
|
Ludan Engineering Co Ltd
TASE:LUDN
|
IL |
|
E
|
Earlyworks Co Ltd
NASDAQ:ELWS
|
JP |
|
Methode Electronics Inc
NYSE:MEI
|
US |
|
F
|
Fraser & Neave Holdings Bhd
KLSE:F&N
|
MY |
|
V
|
Valofe Co Ltd
KOSDAQ:331520
|
KR |
|
Amber International Holding Ltd
NASDAQ:AMBR
|
HK |
|
S
|
Sixt SE
XBER:SIX2
|
DE |
Bankruptcy Probability
Global Blood Therapeutics Inc's probability of bankruptcy is hidden . The solvency score is hidden .
We take all the information about a company's solvency (such as how easily a company can pay interest on its outstanding debt, how much cash it has, the amount of debt, and more) and use it to estimate the probability of bankruptcy.
Solvency Ratios
Solvency Ratios Comparison
Global Blood Therapeutics Inc Competitors
| Country | Company | Market Cap | D/E | D/A |
Interest Coverage |
Altman Z-Score |
Quick Ratio |
Current Ratio |
Cash Ratio |
||
|---|---|---|---|---|---|---|---|---|---|---|---|
| US |
G
|
Global Blood Therapeutics Inc
F:G5B
|
4.6B EUR |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| FR |
|
Pharnext SCA
OTC:PNEXF
|
6T USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Abbvie Inc
NYSE:ABBV
|
374.1B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Amgen Inc
NASDAQ:AMGN
|
188.5B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Gilead Sciences Inc
NASDAQ:GILD
|
175.7B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
|
112.8B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
E
|
Epizyme Inc
F:EPE
|
94.1B EUR |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
|
82B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| NL |
|
argenx SE
XBRU:ARGX
|
41.5B EUR |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| AU |
|
CSL Ltd
ASX:CSL
|
68.5B AUD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
S
|
Seagen Inc
F:SGT
|
39.3B EUR |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Global Blood Therapeutics Inc's probability of bankruptcy is hidden .
The probability of bankruptcy is estimated using credit risk models that assess its financial health, debt levels, interest coverage, and other solvency indicators.
As of the latest report, Global Blood Therapeutics Inc has total debt of 581.9m USD. This includes both short-term (0 USD) and long-term (581.9m USD) debt.
You can find a full breakdown on its Balance Sheet.
